🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Material Removal

According to TikTok, the service has removed violative content and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, positive testimonials and detailed guides for preparing or injecting at home.

Within moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Product Details and Pricing

Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously seen individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially serious health risks”.